The EQ-5D-5L Improves on the EQ-5D-3L for Health-related Quality-of-life Assessment in Patients Undergoing Total Hip Arthroplasty

被引:51
|
作者
Greene, Meridith E. [1 ,2 ,3 ]
Rader, Kevin A. [4 ]
Garellick, Goran [2 ,3 ]
Malchau, Henrik [1 ,2 ,3 ]
Freiberg, Andrew A. [1 ]
Rolfson, Ola [1 ,2 ,3 ]
机构
[1] Massachusetts Gen Hosp, Harris Orthopaed Lab, Boston, MA 02114 USA
[2] Swedish Hip Arthroplasty Register, Gothenburg, Sweden
[3] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Orthopaed, Gothenburg, Sweden
[4] Harvard Univ, Dept Biostat, Cambridge, MA 02138 USA
关键词
STANDARD EQ-5D; 5-LEVEL VERSION; POPULATION;
D O I
10.1007/s11999-014-4091-y
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
The EQ-5D is a generic health survey that can be used to compare improvement across different interventions, measure changes in health-related quality of life over time, or to explore cost-effectiveness among treatments, hospitals, or providers. The original EQ-5D survey has three response options for each of five health dimensions; however, with so few response options, ceiling and floor effects are problematic in some populations. A new version, called the EQ-5D-5L, was developed, which gives respondents five answer options (the "5L" refers to five response levels, which is in contrast to the original survey's three levels). However, the validity of this version has not, to our knowledge, been evaluated in patients undergoing total hip arthroplasty (THA). The purposes of this study were (1) to characterize the redistribution of responses using the new version; (2) to describe the ceiling and floor effects in the current three-level version and identify whether the new EQ-5D-5L survey diminished these effects; and (3) to understand the convergent validity of the new version with the old and the EQ visual analog scale. Both versions of the survey were administered either preoperatively or 1 to 6 years after THA, allowing at least 2 weeks between administrations. Responses to the two versions were compared to determine response redistribution properties, ceiling and floor effects, and convergent validity. Sample sizes were determined so that the study would have 90% power to detect a Spearman correlation over 0.7 when comparing the responses of the three-level survey with the five-level survey and allowing for a rate of 25% loss to followup. Most patients before surgery used the new responses in the majority of dimensions, whereas the patients taking the test after surgery used the new responses predominantly for the pain dimension. The five-level diminished ceiling effects in both groups by up to 30% and diminished floor effects in the pain dimension for patients taking the assessment before surgery by 14%, which was the only dimension in either patient group that had high rates of floor effects. The correlation between the surveys' visual analog scale and response patterns was not different for the two versions of the survey in these populations. The EQ-5D five-level survey appears able to discriminate new health states indistinguishable in the original, which may allow more sensitive measurements of change in patients undergoing THA. The five-level survey should be considered for implementation in local and national registry monitoring of health-related quality of life in patients undergoing THA.
引用
收藏
页码:3383 / 3390
页数:8
相关论文
共 50 条
  • [31] Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patients
    Adrienn Katalin Poór
    Fanni Rencz
    Valentin Brodszky
    László Gulácsi
    Zsuzsanna Beretzky
    Bernadett Hidvégi
    Péter Holló
    Sarolta Kárpáti
    Márta Péntek
    Quality of Life Research, 2017, 26 : 3409 - 3419
  • [32] eq5dmap: A command for mapping between EQ-5D-3L and EQ-5D-5L
    Hernandez-Alava, Monica
    Pudney, Stephen
    STATA JOURNAL, 2018, 18 (02): : 395 - 415
  • [33] Comparing EQ-5D-3L and EQ-5D-5L in the Portuguese general population
    Pereira, Luis N.
    Ferreira, Pedro L.
    Ferreira, Lara N.
    Antunes, Patricia
    QUALITY OF LIFE RESEARCH, 2016, 25 : 92 - 92
  • [34] A Comparison of EQ-5D-3L, EQ-5D-5L, and SF-6D Utilities of Patients with Musculoskeletal Disorders of Different Severity: A Health-Related Quality of Life Approach
    Kontodimopoulos, Nikolaos
    Stamatopoulou, Eleni
    Gazi, Sousana
    Moschou, Dimitra
    Krikelis, Michail
    Talias, Michael A.
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (14)
  • [35] Health Related Quality of Life norm data of the general population in Italy: results using the EQ-5D-3L and EQ-5D-5L instruments
    Scalone, Luciana
    Cortesi, Paolo Angelo
    Ciampichini, Roberta
    Cesana, Giancarlo
    Mantovani, Lorenzo Giovanni
    EPIDEMIOLOGY BIOSTATISTICS AND PUBLIC HEALTH, 2015, 12 (03)
  • [36] The measurement performance of the EQ-5D-5L versus EQ-5D-3L in patients with hidradenitis suppurativa
    Alex Bató
    Valentin Brodszky
    L. Hunor Gergely
    Krisztián Gáspár
    Norbert Wikonkál
    Ágnes Kinyó
    Ákos Szabó
    Zsuzsanna Beretzky
    Andrea Szegedi
    Éva Remenyik
    Norbert Kiss
    Miklós Sárdy
    Fanni Rencz
    Quality of Life Research, 2021, 30 : 1477 - 1490
  • [37] THE MEASUREMENT PERFORMANCE OF THE EQ-5D-5L VERSUS EQ-5D-3L IN PATIENTS WITH HIDRADENITIS SUPPURATIVA
    Bato, A.
    Brodszky, V
    Gergely, H. L.
    Gaspar, K.
    Wikonkal, N.
    Kinyo, A.
    Beretzky, Z.
    Szegedi, A.
    Remenyik, E.
    Kiss, N. F.
    Sardy, M.
    Banvolgyi, A.
    Rencz, F.
    VALUE IN HEALTH, 2020, 23 : S748 - S748
  • [38] Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients
    Pattanaphesaj, Juntana
    Thavorncharoensap, Montarat
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2015, 13
  • [39] Is EQ-5D-5L better over time? A head-to-head comparison of responsiveness of the EQ-5D-3L and EQ-5D-5L
    Buchholz, Ines
    Janssen, Mathieu
    Golicki, Dominik
    Bonsel, Gouke
    QUALITY OF LIFE RESEARCH, 2019, 28 : S163 - S163
  • [40] Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients
    Juntana Pattanaphesaj
    Montarat Thavorncharoensap
    Health and Quality of Life Outcomes, 13